We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.
An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Bollini, PPampallona, SOrza, MJAdams, MEChalmers, TC. Anti-psychotic drugs: is more worse? A meta-analysis of the published randomized control trials.Psychol Med1994; 24: 307–316CrossRefGoogle Scholar
2
Fleischhacker, WWMeise, UGünther, VKurz, M. Compliance with anti-psychotic drug treatment: influence of sideeffects.Acta Psychiatr Scand1994; 89 Suppl 382: 11–15Google Scholar
3
Pach, JOsterheider, MFinkbeiner, TGreger, JHaug, HJStrobl, R. Differential dosage of flupenthixol–decanoate for relapse prevention in schizophrenic patients – Results of the MARS study.Psychopharmakotherapie1998; 5: 150–155Google Scholar
4
Stanton, J. Weight gain associated with neuroleptic medication: a review.Schizophr Bull1995; 21: 463–472CrossRefGoogle ScholarPubMed
Comments
No Comments have been published for this article.